Overactive Bladder Syndrome
NCT05151081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87
Last updated 2021-12-09
Summary
Purpose:
A lot of etiological factors related to overactive bladder (OAB) has been investigated. However, the role of primary nocturnal enuresis (NE), which is characterized with childhood night time incontinence, in the etiology of OAB is controversial. This study aims to evaluate the effect of NE in patients diagnosed with OAB.
Metod Between january-september 2021, the data of patients who applied to the urology outpatientclinic with OAB symptoms were collected. Patients with a history of chronic systemic disease, previous medical treatment for OAB and who did not accept to join the study were excluded. According to the diagnosis of childhood NE, patients were divided into two groups. Demographic data hav been recorded. Frequency of incontinence, number of day time void and nocturia were evaluated according to a 3 day voiding diary. Inaddition, max. Urinary flowr atio (Qmax), bladder Wall thickness and postvoid residual volüme rates were determined using uroflowmetry and pelvic ultrasound.
Conditions
- Overactive Bladder Syndrome
- Enuresis, Nocturnal
Interventions
- OTHER
-
basicly
Do not repeat information already included in arm/group descriptions.
Sponsors & Collaborators
-
Hisar Intercontinental Hospital
lead OTHER
Principal Investigators
-
Basri Cakiroglu · Hisar Intercontinental Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-03
- Primary Completion
- 2021-07-03
- Completion
- 2021-10-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Ability to Awaken in Nonmonosymptomatic Enuresis
NCT02845648 ·Status: COMPLETED
-
Urinary Biomarkers in Overactive Bladder in Children
NCT02704013 ·Status: UNKNOWN ·Phase: NA
-
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Herbal Patch for Overactive Bladder
NCT03532789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder
NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Behavioural Therapy With Checklist for Overactive Bladder
NCT03662893 ·Status: COMPLETED ·Phase: NA
-
Uroflowmetry and Nocturnal Enuresis
NCT07028645 ·Status: ACTIVE_NOT_RECRUITING
-
Acupuncture for Overactive Bladder in Adults
NCT05158361 ·Status: RECRUITING ·Phase: NA
-
Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing
NCT01819168 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of Desmopressin Oral Lyophilisate Formulation in the Paediatric Population
NCT02584231 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Diversity in Patients With OAB
NCT05903105 ·Status: NOT_YET_RECRUITING
-
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
NCT00224016 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder
NCT01539707 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity
NCT00495053 ·Status: TERMINATED ·Phase: PHASE1
-
Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life
NCT07044778 ·Status: COMPLETED
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
NCT00335660 ·Status: TERMINATED ·Phase: PHASE2
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
NCT01043666 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
NCT00245479 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder
NCT00795925 ·Status: COMPLETED ·Phase: PHASE2